rxstat › Classes › All Other Therapeutic Products
All Other Therapeutic Products: shortage status in Canada
9 of the 18 all other therapeutic products rxstat tracks are currently in shortage in Canada, including 1 designated Tier 3 (most serious) by Health Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Mesna (Uromitexan) Widespread shortage 1 of 3 reported products affected
Deferasirox (Jadenu) Partial shortage 2 of 25 reported products affected · est. return Nov 12, 2026
Deferoxamine (Desferal) Partial shortage 1 of 3 reported products affected · est. return Nov 23, 2026
Dexrazoxane (Zinecard) Partial shortage 1 of 3 reported products affected
Leucovorin Partial shortage 1 of 6 reported products affected · est. return Jan 31, 2027
Methylene Blue Partial shortage 1 of 2 reported products affected
Naloxone Partial shortage 1 of 8 reported products affected
Polystyrene Sulfonate (Solystat) Partial shortage 2 of 6 reported products affected · est. return Jan 22, 2027
Polystyrene Sulfonate (Resonium Calcium) Partial shortage 1 of 2 reported products affected
Alcohol Anhydrous Discontinued 0 of 1 reported products affected
Cobicistat (Tybost) Discontinued 0 of 1 reported products affected
Digoxin Immune Fab (Digifab) No current shortage
Dimercaprol (Bal In Oil) Discontinued 0 of 1 reported products affected
Hydroxocobalamin (Cyanokit) No current shortage
Lanthanum (Fosrenol) Discontinued 0 of 4 reported products affected
Protamine No current shortage
Sevelamer (Renagel) No current shortage
Sevelamer Carbonate (Renvela) No current shortage
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.